Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Bloomfield

Showing results (241-250 of 289) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemiaM S Tallman, J W Andersen, C A Schiffer, et al.
The American Journal of Medicine|December 1, 1988
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatmentD D Hurd, T W LeBien, L C Lasky, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapseL M Secker-Walker, G Alimena, C D Bloomfield, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Science (New York, N.Y.)|October 16, 1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringT R Golub, D K Slonim, P Tamayo, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|July 21, 2016
Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2A-K Eisfeld, J Kohlschmidt, K Mrózek, et al.
Pageof 29

Showing results (241-250 of 289) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|October 9, 1997
All-trans-retinoic acid in acute promyelocytic leukemiaM S Tallman, J W Andersen, C A Schiffer, et al.
The American Journal of Medicine|December 1, 1988
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatmentD D Hurd, T W LeBien, L C Lasky, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapseL M Secker-Walker, G Alimena, C D Bloomfield, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Science (New York, N.Y.)|October 16, 1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringT R Golub, D K Slonim, P Tamayo, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|July 21, 2016
Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2A-K Eisfeld, J Kohlschmidt, K Mrózek, et al.
Pageof 29